Cyclin Dependent Kinase Inhibitor Antibody Sampler Kit #9867
Inquiry Info. # 9867
Please see our recommended alternatives.
Product Information
Kit Usage Information
Protocols
- 2557: Western Blotting, Immunoprecipitation (Magnetic), Immunofluorescence
- 2896: Western Blotting, Immunoprecipitation (Agarose)
- 2947: Western Blotting, Immunoprecipitation (Agarose), Immunohistochemistry (Paraffin), Immunofluorescence, Flow
- 3686: Western Blotting, Immunoprecipitation (Magnetic), Immunofluorescence, Flow
- 3698: Western Blotting, Immunofluorescence
- 4822: Western Blotting, Flow
- 7074: Western Blotting
- 7076: Western Blotting
Product Description
The Cyclin Dependent Kinase Inhibitor Antibody Sampler Kit provides an economical means to investigate cyclin dependent kinase inhibitors. The kit contains enough primary and secondary antibody to perform four western blot experiments.
Background
The cyclin-dependent kinase complex can exist as an active, binary complex containing cyclin and kinase or as an inactive, ternary complex when the pair associates with a CKI inhibitor. Some of these component proteins act selectively within their cyclin/CDK complex while other proteins exhibit a broader range of functions, including roles apart from the CDK complex (1,2). The INK4 family is characterized by 32 amino acid ankyrin repeats that mediate specific interactions with CDK4/6 and cyclinD/CDK4/6 (3). The Kip family includes p27, perhaps one of the most versatile proteins by virtue of its inherently context-adaptive structure. p27 has been implicated in regulatory roles of cell cycle progression, malignant transformation, cell motility, and differentiation (4,5). Similarly, p21 interacts with several CDK complexes during different cell cycle stages to exert different effects; p21 is regulated by phosphorylation and ubiquitin-mediated degradation (6,7).
- Harper, J.W. (1997) Cancer Surv 29, 91-107.
- Viallard, J.F. et al. (2001) Cancer Radiother 5, 109-29.
- Noh, S.J. et al. (1999) Cancer Res 59, 558-64.
- Borriello, A. et al. (2007) Cell Cycle 6, 1053-61.
- Chassot, A.A. et al. (2008) Cell Cycle 7, 2038-46.
- Kim, Y. et al. (2008) Genes Dev 22, 2507-19.
- Abbas, T. and Dutta, A. (2009) Nat Rev Cancer 9, 400-14.
Alternate Names
cip1; cki; Kip1; p21; p27; waf1
限制使用
除非 CST 的合法授书代表以书面形式书行明确同意,否书以下条款适用于 CST、其关书方或分书商提供的书品。 任何书充本条款或与本条款不同的客书条款和条件,除非书 CST 的合法授书代表以书面形式书独接受, 否书均被拒书,并且无效。
专品专有“专供研究使用”的专专或专似的专专声明, 且未专得美国食品和专品管理局或其他外国或国内专管机专专专任何用途的批准、准专或专可。客专不得将任何专品用于任何专断或治专目的, 或以任何不符合专专声明的方式使用专品。CST 专售或专可的专品提供专作专最专用专的客专,且专用于研专用途。将专品用于专断、专防或治专目的, 或专专售(专独或作专专成)或其他商专目的而专专专品,均需要 CST 的专独专可。客专:(a) 不得专独或与其他材料专合向任何第三方出售、专可、 出借、捐专或以其他方式专专或提供任何专品,或使用专品制造任何商专专品,(b) 不得复制、修改、逆向工程、反专专、 反专专专品或以其他方式专专专专专品的基专专专或技专,或使用专品开专任何与 CST 的专品或服专专争的专品或服专, (c) 不得更改或专除专品上的任何商专、商品名称、徽专、专利或版专声明或专专,(d) 只能根据 CST 的专品专售条款和任何适用文档使用专品, (e) 专遵守客专与专品一起使用的任何第三方专品或服专的任何专可、服专条款或专似专专
For Research Use Only. Not for Use in Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
All other trademarks are the property of their respective owners. Visit our
Trademark Information page.